Clusterin Role in Hepatocellular Carcinoma Patients Treated With Oxaliplatin

Bioscience Reports- Netherlands

doi 10.1042/bsr20200071

Full Text

Abstract

Available in

Categories

Molecular Biology

Date

February 1, 2020

Authors

Publisher

Portland Press Ltd.

Related search

Secretory Clusterin Mediates Oxaliplatin Resistance via the Gadd45a/Pi3k/Akt Signaling Pathway in Hepatocellular Carcinoma

Journal of Cancer

English

Attenuation of Liver Stiffness in Sorafenib-Treated Patients With Advanced Hepatocellular Carcinoma

Hepatoma Research

English

Early Α-Fetoprotein Response Predicts Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib

Journal of Hepatocellular Carcinoma

English

Determining and Incorporating the Optimal Predictive Biomarkers in Hepatocellular Carcinoma Patients Treated With Radiotherapy

International Journal of Radiation Oncology Biology Physics

Cancer Research

Nuclear Medicine

English

Skeletal Muscle Depletion Predicts the Prognosis of Patients With Hepatocellular Carcinoma Treated With Radiotherapy

Frontiers in Oncology

Cancer Research

English

A Prognostic Score for Patients With Intermediate-Stage Hepatocellular Carcinoma Treated With Transarterial Chemoembolization

Multidisciplinary

English

The Role of Novel Prognostic Scores for Patients With Hepatocellular Carcinoma

International Journal of Radiation Oncology Biology Physics

Cancer Research

Nuclear Medicine

English

Baseline Albumin-Bilirubin (ALBI) in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiotherapy (SBRT)

International Journal of Radiation Oncology Biology Physics

Cancer Research

Nuclear Medicine

English

The Three Criteria for Radiological Response on Survival in Patients With Hepatocellular Carcinoma Treated With Lenvatinib

Hepatology Research

Infectious Diseases

English